Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Ossium Health, Inc.
Terns, Inc.
M.D. Anderson Cancer Center
Children's Oncology Group
Novartis
Stanford University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Astex Pharmaceuticals, Inc.
Sun Pharma Advanced Research Company Limited
Columbia University
M.D. Anderson Cancer Center
Indiana University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Charite University, Berlin, Germany
Fate Therapeutics
Takeda
Kartos Therapeutics, Inc.
Teva Branded Pharmaceutical Products R&D, Inc.
Novartis
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
Novartis
Novartis
Novartis
University Health Network, Toronto
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Bio-Path Holdings, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fusion Pharma LLC
Fred Hutchinson Cancer Center
Mirror Biologics, Inc.
Hospital de Clinicas de Porto Alegre
Cell Medica Ltd
Il-Yang Pharm. Co., Ltd.
National Institutes of Health Clinical Center (CC)
Stanford University
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
Prism Pharma Co., Ltd.
Fred Hutchinson Cancer Center
Traws Pharma, Inc.
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
Singapore General Hospital